Axon Enterprise (NASDAQ:AXON) experienced a sharp sell-off on Tuesday, with shares plummeting 8.52% to close at $518.30. The decline erased approximately $3.9 billion in market value, bringing the company's market capitalization to $46.03 billion. The stock briefly touched an intraday low of $511.18 before recovering slightly to $521.20 in after-hours trading.
The sell-off was not isolated to Axon. The broader market also faced headwinds, with the Nasdaq Composite falling 1.03% and the S&P 500 declining 0.70%. Axon underperformed the Nasdaq by 7.49 percentage points, a significant gap that highlights investor concerns about high-growth technology stocks in a rising interest rate environment.
Rising Bond Yields Weigh on Growth Premium
The primary catalyst for Tuesday's decline appears to be the continued rise in bond yields, with the 10-year Treasury yield reaching 4.79%. Higher yields increase the discount rate applied to future earnings, making high-multiple growth stocks like Axon less attractive. Axon's current valuation stands at approximately 12.7 times its annualized second-quarter sales, a multiple that remains elevated despite the sell-off.
"The market is repricing growth assets as bond yields climb," said analysts at a major brokerage. "Axon's premium valuation is now under scrutiny, and investors are demanding more evidence of cash flow generation."
Strong Revenue Growth, But Cash Conversion Lags
Axon's fundamental business performance remains robust. Second-quarter revenue surged 35.3% year-over-year to $904.4 million, driven by strong growth in both software and services and connected devices. Software and services revenue climbed 36% to $398 million, while connected devices revenue rose 35% to $507 million. Annual recurring revenue grew 39% to $1.6 billion, and future contracted bookings jumped 41% to $15.1 billion.
However, margin pressures and weak cash flow are raising concerns. Software and services gross margin declined to 71.3% from 75.6% in the prior year, attributed to increased professional services costs and expenses related to new product launches. Adjusted EBITDA came in at $242 million, representing a 26.8% margin, but free cash flow was negative $1 million for the quarter.
Chief Financial Officer Brittany Bagley acknowledged the cash flow situation but expressed confidence in the company's trajectory. "We maintain line of sight to strong free cash flow generation," she said during the earnings call, projecting $450 million for fiscal 2026.
Analyst Sentiment Remains Positive
Despite the sharp sell-off, Wall Street analysts remain largely bullish on Axon. According to Google Finance, there are 10 buy ratings, one hold, and zero sell ratings on the stock. The average price target stands at $731.50, implying a potential upside of approximately 41% from current levels. However, it's worth noting that most of these targets were set before the recent sell-off and may not fully reflect the current market conditions.
Management has several upcoming appearances at investor conferences, including Goldman Sachs on September 8, Wolfe Research on September 9, and Piper Sandler on September 15. These events could provide opportunities for management to reassure investors about the company's growth prospects and cash flow outlook.
Market Context and Outlook
The sell-off in Axon is part of a broader trend affecting growth stocks as bond yields rise. Higher oil prices and Treasury yields have put pressure on equities, particularly those with high valuations. The increased trading volume, which was 66% higher than the recent average, suggests that the repricing was not a light-trade phenomenon but rather a significant shift in investor sentiment.
Looking ahead, Axon's valuation could face further pressure if bond yields continue to climb. Additionally, slower cash conversion, weaker software margins, or delays in public-sector procurement could exacerbate the situation. Conversely, a quick drop in yields or a surge in bookings would undermine the bearish view.
For now, investors are seeking evidence that Axon's growth exceeding 30% can translate into sustained free cash flow. The after-hours recovery was modest, indicating that the market remains cautious. As bond yields demand a steeper price for waiting, Axon's growth premium is now a question of duration.
